Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetics of lopinavir-ritonavir with and without nonnucleoside reverse transcriptase inhibitors in Ugandan HIV-infected adults.
Kityo C, Walker AS, Dickinson L, Lutwama F, Kayiwa J, Ssali F, Nalumenya R, Tumukunde D, Munderi P, Reid A, Gilks CF, Gibb DM, Khoo S; DART Trial Team. Kityo C, et al. Among authors: kayiwa j. Antimicrob Agents Chemother. 2010 Jul;54(7):2965-73. doi: 10.1128/AAC.01198-09. Epub 2010 Apr 26. Antimicrob Agents Chemother. 2010. PMID: 20421406 Free PMC article. Clinical Trial.
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial.
Paton NI, Kityo C, Thompson J, Nankya I, Bagenda L, Hoppe A, Hakim J, Kambugu A, van Oosterhout JJ, Kiconco M, Bertagnolio S, Easterbrook PJ, Mugyenyi P, Walker AS; Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team. Paton NI, et al. Lancet HIV. 2017 Aug;4(8):e341-e348. doi: 10.1016/S2352-3018(17)30065-6. Epub 2017 May 8. Lancet HIV. 2017. PMID: 28495562 Free PMC article. Clinical Trial.
Assessment of second-line antiretroviral regimens for HIV therapy in Africa.
Paton NI, Kityo C, Hoppe A, Reid A, Kambugu A, Lugemwa A, van Oosterhout JJ, Kiconco M, Siika A, Mwebaze R, Abwola M, Abongomera G, Mweemba A, Alima H, Atwongyeire D, Nyirenda R, Boles J, Thompson J, Tumukunde D, Chidziva E, Mambule I, Arribas JR, Easterbrook PJ, Hakim J, Walker AS, Mugyenyi P; EARNEST Trial Team. Paton NI, et al. N Engl J Med. 2014 Jul 17;371(3):234-47. doi: 10.1056/NEJMoa1311274. N Engl J Med. 2014. PMID: 25014688 Free article. Clinical Trial.
Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.
Musiime V, Cook A, Kayiwa J, Zangata D, Nansubuga C, Arach B, Kenny J, Wavamunno P, Komunyena J, Kabamba D, Asiimwe AR, Mirembe G, Abongomera G, Mulenga V, Kekitiinwa A, Kityo C, Walker SA, Klein N, Gibb DM; CHAPAS-3 trial team. Musiime V, et al. Among authors: kayiwa j. Antivir Ther. 2014;19(3):269-76. doi: 10.3851/IMP2695. Epub 2013 Oct 25. Antivir Ther. 2014. PMID: 24717427 Clinical Trial.
The 2023 South Sudanese outbreak of Hepatitis E emphasizes ongoing circulation of genotype 1 in North, Central, and East Africa.
Orf GS, Bbosa N, Berg MG, Downing R, Weiss SL, Ssemwanga D, Ssekagiri A, Ashraf S, da Silva Filipe A, Kiiza R, Buule J, Namagembe HS, Nabirye SE, Kayiwa J, Deng LL, Wani G, Maror JA, Baguma A, Mogga JJH, Kamili S, Thomson EC, Kaleebu P, Cloherty GA. Orf GS, et al. Among authors: kayiwa j. Infect Genet Evol. 2024 Oct;124:105667. doi: 10.1016/j.meegid.2024.105667. Epub 2024 Sep 7. Infect Genet Evol. 2024. PMID: 39251076 Free PMC article.
Ebola disease outbreak caused by the Sudan virus in Uganda, 2022: a descriptive epidemiological study.
Kabami Z, Ario AR, Harris JR, Ninsiima M, Ahirirwe SR, Ocero JRA, Atwine D, Mwebesa HG, Kyabayinze DJ, Muruta AN, Kagirita A, Tegegn Y, Nanyunja M, Kizito SN, Kadobera D, Kwesiga B, Gidudu S, Migisha R, Makumbi I, Eurien D, Elyanu PJ, Ndyabakira A, Naiga HN, Zalwango JF, Agaba B, Kawungezi PC, Zalwango MG, King P, Simbwa BN, Akunzirwe R, Wanyana MW, Zavuga R, Kiggundu T; Uganda Ebola Response Team. Kabami Z, et al. Lancet Glob Health. 2024 Oct;12(10):e1684-e1692. doi: 10.1016/S2214-109X(24)00260-2. Epub 2024 Aug 30. Lancet Glob Health. 2024. PMID: 39222652 Free PMC article.
HETEROGENEOUS EXPANSION OF POLYMORPHONUCLEAR MYELOID-DERIVED SUPPRESSOR CELLS DISTINGUISHES HIGH-RISK SEPSIS IMMUNOPHENOTYPES IN UGANDA.
Cummings MJ, Guichard V, Owor N, Ochar T, Kiwubeyi M, Nankwanga R, Kibisi R, Kassaja C, Ross JE, Postler TS, Kayiwa J, Reynolds SJ, Nakibuuka MC, Nakaseegu J, Lutwama JJ, Lipkin WI, Ghosh S, Bakamutumaho B, O'Donnell MR. Cummings MJ, et al. Among authors: kayiwa j. Shock. 2024 Sep 1;62(3):336-343. doi: 10.1097/SHK.0000000000002403. Epub 2024 May 30. Shock. 2024. PMID: 39012778
92 results